Pharmaceuticals - Global Group of Eight (G8) Industry Guide

Published by: Datamonitor

Published: Apr. 1, 2009 - 238 Pages

Table of Contents

CHAPTER 1 INTRODUCTION

1.1 What is this report about?

1.2 Who is the target reader?

1.3 How to use this report

1.4 Definitions

CHAPTER 2 GROUP OF EIGHT (G8) PHARMACEUTICALS INDUSTRY OUTLOOK

CHAPTER 3 PHARMACEUTICALS IN CANADA

3.1 Market Overview

3.2 Market Value

3.3 Market Segmentation I

3.4 Market Segmentation II

3.5 Market Share

3.6 Five Forces Analysis

3.7 Leading Companies

3.8 Market Forecasts

3.9 Macroeconomic Indicators

CHAPTER 4 PHARMACEUTICALS IN FRANCE

4.1 Market Overview

4.2 Market Value

4.3 Market Segmentation I

4.4 Market Segmentation II

4.5 Market Share

4.6 Five Forces Analysis

4.7 Leading Companies

4.8 Market Forecasts

4.9 Macroeconomic Indicators

CHAPTER 5 PHARMACEUTICALS IN GERMANY

5.1 Market Overview

5.2 Market Value

5.3 Market Segmentation I

5.4 Market Segmentation II

5.5 Market Share

5.6 Five Forces Analysis

5.7 Leading Companies

5.8 Market Forecasts

5.9 Macroeconomic Indicators

CHAPTER 6 PHARMACEUTICALS IN ITALY

6.1 Market Overview

6.2 Market Value

6.3 Market Segmentation I

6.4 Market Segmentation II

6.5 Market Share

6.6 Five Forces Analysis

6.7 Leading Companies

6.8 Market Forecasts

6.9 Macroeconomic Indicators

CHAPTER 7 PHARMACEUTICALS IN JAPAN

7.1 Market Overview

7.2 Market Value

7.3 Market Segmentation I

7.4 Market Segmentation II

7.5 Market Share

7.6 Five Forces Analysis

7.7 Leading Companies

7.8 Market Forecasts

7.9 Macroeconomic Indicators

CHAPTER 8 PHARMACEUTICALS IN RUSSIA

8.1 Market Overview

8.2 Market Value

8.3 Market Segmentation I

8.4 Market Segmentation II

8.5 Market Share

8.6 Five Forces Analysis

8.7 Leading Companies

8.8 Market Forecasts

8.9 Macroeconomic Indicators

CHAPTER 9 PHARMACEUTICALS IN THE UNITED KINGDOM

9.1 Market Overview

9.2 Market Value

9.3 Market Segmentation I

9.4 Market Segmentation II

9.5 Market Share

9.6 Five Forces Analysis

9.7 Leading Companies

9.8 Market Forecasts

9.9 Macroeconomic Indicators

CHAPTER 10 PHARMACEUTICALS IN THE UNITED STATES

10.1 Market Overview

10.2 Market Value

10.3 Market Segmentation I

10.4 Market Segmentation II

10.5 Market Share

10.6 Five Forces Analysis

10.7 Leading Companies

10.8 Market Forecasts

10.9 Macroeconomic Indicators

CHAPTER 11 APPENDIX

11.1 Data Research Methodology

LIST OF TABLES

Table 1: G8 Pharmaceuticals industry, revenue ($ bn), 2004-13

Table 2: G8 Pharmaceuticals industry, revenue by country ($ bn) 2004-2008(e)

Table 3: G8 Pharmaceuticals industry forecast, revenue by country ($ bn) 2008-2013

Table 4: Canada Pharmaceuticals Market Value: $ billion, 2004-2008

Table 5: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 6: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 7: Canada Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 8: Key Facts: Pfizer Inc

Table 9: Key Financials: Pfizer Inc

Table 10: Key Facts: AstraZeneca PLC

Table 11: Key Financials: AstraZeneca PLC

Table 12: Key Facts: Apotex, Inc.

Table 13: Key Facts: Johnson & Johnson

Table 14: Key Financials: Johnson & Johnson

Table 15: Canada Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 16: Canada Size of Population (million) , 2004-2008

Table 17: Canada GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 18: Canada Inflation, 2004-2008

Table 19: Canada Exchange Rate, 2004-2008

Table 20: France Pharmaceuticals Market Value: $ billion, 2004-2008

Table 21: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 22: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 23: France Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 24: Key Facts: Sanofi-Aventis SA

Table 25: Key Financials: Sanofi-Aventis SA

Table 26: Key Facts: GlaxoSmithKline Plc

Table 27: Key Financials: GlaxoSmithKline Plc

Table 28: Key Facts: Pfizer Inc

Table 29: Key Financials: Pfizer Inc

Table 30: France Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 31: France Size of Population (million) , 2004-2008

Table 32: France GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 33: France Inflation, 2004-2008

Table 34: France Exchange Rate, 2004-2008

Table 35: Germany Pharmaceuticals Market Value: $ billion, 2004-2008

Table 36: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 37: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 38: Germany Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 39: Key Facts: Pfizer Inc

Table 40: Key Financials: Pfizer Inc

Table 41: Key Facts: Sanofi-Aventis SA

Table 42: Key Financials: Sanofi-Aventis SA

Table 43: Key Facts: AstraZeneca PLC

Table 44: Key Financials: AstraZeneca PLC

Table 45: Key Facts: Roche Holding Ltd.

Table 46: Key Financials: Roche Holding Ltd.

Table 47: Germany Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 48: Germany Size of Population (million) , 2004-2008

Table 49: Germany GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 50: Germany Inflation, 2004-2008

Table 51: Germany Exchange Rate, 2004-2008

Table 52: Italy Pharmaceuticals Market Value: $ billion, 2004-2008

Table 53: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 54: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 55: Italy Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 56: Key Facts: Sanofi-Aventis SA

Table 57: Key Financials: Sanofi-Aventis SA

Table 58: Key Facts: Menarini Group

Table 59: Key Facts: Pfizer Inc

Table 60: Key Financials: Pfizer Inc

Table 61: Key Facts: GlaxoSmithKline Plc

Table 62: Key Financials: GlaxoSmithKline Plc

Table 63: Italy Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 64: Italy Size of Population (million) , 2004-2008

Table 65: Italy GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 66: Italy Inflation, 2004-2008

Table 67: Italy Exchange Rate, 2004-2008

Table 68: Japan Pharmaceuticals Market Value: $ billion, 2004-2008

Table 69: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 70: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 71: Japan Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 72: Key Facts: Takeda Pharmaceutical Company Limited

Table 73: Key Financials: Takeda Pharmaceutical Company Limited

Table 74: Key Facts: Astellas Pharma

Table 75: Key Financials: Astellas Pharma

Table 76: Key Facts: Daiichi Sankyo Co., Ltd.

Table 77: Key Facts: Pfizer Inc

Table 78: Key Financials: Pfizer Inc

Table 79: Japan Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 80: Japan Size of Population (million) , 2004-2008

Table 81: Japan GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 82: Japan Inflation, 2004-2008

Table 83: Japan Exchange Rate, 2004-2008

Table 84: Russia Pharmaceuticals Market Value: $ billion, 2004-2008

Table 85: Russia Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 86: Russia Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 87: Russia Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 88: Key Facts: Novartis AG

Table 89: Key Financials: Novartis AG

Table 90: Key Facts: Sanofi-Aventis SA

Table 91: Key Financials: Sanofi-Aventis SA

Table 92: Key Facts: Menarini Group

Table 93: Russia Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 94: Russia Size of Population (million) , 2004-2008

Table 95: Russia GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 96: Russia Inflation, 2004-2008

Table 97: Russia Exchange Rate, 2004-2008

Table 98: United Kingdom Pharmaceuticals Market Value: $ billion, 2004-2008

Table 99: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 100: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 101: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 102: Key Facts: Pfizer Inc

Table 103: Key Financials: Pfizer Inc

Table 104: Key Facts: GlaxoSmithKline Plc

Table 105: Key Financials: GlaxoSmithKline Plc

Table 106: Key Facts: Sanofi-Aventis SA

Table 107: Key Financials: Sanofi-Aventis SA

Table 108: Key Facts: AstraZeneca PLC

Table 109: Key Financials: AstraZeneca PLC

Table 110: United Kingdom Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 111: United Kingdom Size of Population (million) , 2004-2008

Table 112: United Kingdom GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 113: United Kingdom Inflation, 2004-2008

Table 114: United Kingdom Exchange Rate, 2004-2008

Table 115: United States Pharmaceuticals Market Value: $ billion, 2004-2008

Table 116: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 117: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 118: United States Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 119: Key Facts: Pfizer Inc

Table 120: Key Financials: Pfizer Inc

Table 121: Key Facts: GlaxoSmithKline Plc

Table 122: Key Financials: GlaxoSmithKline Plc

Table 123: Key Facts: Merck & Co., Inc.

Table 124: Key Financials: Merck & Co., Inc.

Table 125: Key Facts: Johnson & Johnson

Table 126: Key Financials: Johnson & Johnson

Table 127: United States Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 128: United States Size of Population (million) , 2004-2008

Table 129: United States GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 130: United States Inflation, 2004-2008

LIST OF FIGURES

Figure 1: G8 Pharmaceuticals industry, revenue ($ bn) 2004-2013

Figure 2: G8 Pharmaceuticals industry, revenue by country (%) 2004-2013

Figure 3: G8 Pharmaceuticals industry, revenue by country ($ bn) 2004-2008(e)

Figure 4: G8 Pharmaceuticals industry forecast, revenue by country ($ bn) 2008-2013

Figure 5: Canada Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 6: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 7: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 8: Canada Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 9: Forces Driving Competition in the Pharmaceuticals Market in Canada

Figure 10: Drivers of Buyer Power in the Pharmaceuticals Market in Canada

Figure 11: Drivers of Supplier Power in the Pharmaceuticals Market in Canada

Figure 12: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Canada

Figure 13: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Canada

Figure 14: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Canada

Figure 15: Revenues & Profitability: Pfizer Inc

Figure 16: Revenues & Profitability: AstraZeneca PLC

Figure 17: Revenues & Profitability: Johnson & Johnson

Figure 18: Canada Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Figure 19: France Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 20: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 21: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 22: France Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 23: Forces Driving Competition in the Pharmaceuticals Market in France

Figure 24: Drivers of Buyer Power in the Pharmaceuticals Market in France

Figure 25: Drivers of Supplier Power in the Pharmaceuticals Market in France

Figure 26: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in France

Figure 27: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in France

Figure 28: Drivers of Degree of Rivalry in the Pharmaceuticals Market in France

Figure 29: Revenues & Profitability: Sanofi-Aventis SA

Figure 30: Revenues & Profitability: GlaxoSmithKline Plc

Figure 31: Revenues & Profitability: Pfizer Inc

Figure 32: France Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Figure 33: Germany Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 34: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 35: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 36: Germany Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 37: Forces Driving Competition in the Pharmaceuticals market in Germany

Figure 38: Drivers of Buyer Power in the Pharmaceuticals market in Germany

Figure 39: Drivers of Supplier Power in the Pharmaceuticals market in Germany

Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals market in Germany

Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals market in Germany

Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals market in Germany

Figure 43: Revenues & Profitability: Pfizer Inc

Figure 44: Revenues & Profitability: Sanofi-Aventis SA

Figure 45: Revenues & Profitability: AstraZeneca PLC

Figure 46: Revenues & Profitability: Roche Holding Ltd.

Figure 47: Germany Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Figure 48: Italy Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 49: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 50: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 51: Italy Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 52: Forces Driving Competition in the Pharmaceuticals Market in Italy

Figure 53: Drivers of Buyer Power in the Pharmaceuticals Market in Italy

Figure 54: Drivers of Supplier Power in the Pharmaceuticals Market in Italy

Figure 55: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Italy

Figure 56: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Italy

Figure 57: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Italy

Figure 58: Revenues & Profitability: Sanofi-Aventis SA

Figure 59: Revenues & Profitability: Pfizer Inc

Figure 60: Revenues & Profitability: GlaxoSmithKline Plc

Figure 61: Italy Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Figure 62: Japan Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 63: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 64: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 65: Japan Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 66: Forces Driving Competition in the Pharmaceuticals Market in Japan

Figure 67: Drivers of Buyer Power in the Pharmaceuticals Market in Japan

Figure 68: Drivers of Supplier Power in the Pharmaceuticals Market in Japan

Figure 69: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Japan

Figure 70: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Japan

Figure 71: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Japan

Figure 72: Revenues & Profitability: Takeda Pharmaceutical Company Limited

Figure 73: Revenues & Profitability: Astellas Pharma

Figure 74: Revenues & Profitability: Pfizer Inc

Figure 75: Japan Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Figure 76: Russia Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 77: Russia Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 78: Russia Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 79: Russia Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 80: Forces Driving Competition in the Pharmaceuticals Market in Russia

Figure 81: Drivers of Buyer Power in the Pharmaceuticals Market in Russia

Figure 82: Drivers of Supplier Power in the Pharmaceuticals Market in Russia

Figure 83: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Russia

Figure 84: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Russia

Figure 85: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Russia

Figure 86: Revenues & Profitability: Novartis AG

Figure 87: Revenues & Profitability: Sanofi-Aventis SA

Figure 88: Russia Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Figure 89: United Kingdom Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 90: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 91: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 92: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 93: Forces Driving Competition in the Pharmaceuticals Market in the UK

Figure 94: Drivers of Buyer Power in the Pharmaceuticals Market in the UK

Figure 95: Drivers of Supplier Power in the Pharmaceuticals Market in the UK

Figure 96: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the UK

Figure 97: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the UK

Figure 98: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the UK

Figure 99: Revenues & Profitability: Pfizer Inc

Figure 100: Revenues & Profitability: GlaxoSmithKline Plc

Figure 101: Revenues & Profitability: Sanofi-Aventis SA

Figure 102: Revenues & Profitability: AstraZeneca PLC

Figure 103: United Kingdom Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Figure 104: United States Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 105: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 106: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 107: United States Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 108: Forces Driving Competition in the Pharmaceutical Market in the US

Figure 109: Drivers of Buyer Power in the Pharmaceutical Market in the US

Figure 110: Drivers of Supplier Power in the Pharmaceutical Market in the US

Figure 111: Factors Influencing the Likelihood of New Entrants in the Pharmaceutical Market in the US

Figure 112: Factors Influencing the Threat of Substitutes in the Pharmaceutical Market in the US

Figure 113: Drivers of Degree of Rivalry in the Pharmaceutical Market in the US

Figure 114: Revenues & Profitability: Pfizer Inc

Figure 115: Revenues & Profitability: GlaxoSmithKline Plc

Figure 116: Revenues & Profitability: Merck & Co., Inc.

Figure 117: Revenues & Profitability: Johnson & Johnson

Figure 118: United States Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Abstract

• Contains an executive summary and data on value, volume and segmentation
• Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country. .
• Includes a five-year forecast of the industry

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.